Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canal.
Suilane Coelho Ribeiro
No relevant relationships to disclose
Camila Venchiarutti
No relevant relationships to disclose
Rachel Riechelmann
No relevant relationships to disclose
Erlon Gil
No relevant relationships to disclose
Caio Nahas
No relevant relationships to disclose
Renata Coudry
No relevant relationships to disclose
Daniela Freitas
No relevant relationships to disclose
Daniel F. Saragiotto
No relevant relationships to disclose
Fernando Arruda
No relevant relationships to disclose
Rodrigo Azambuja
No relevant relationships to disclose
Paulo Hoff
No relevant relationships to disclose